Connect your AI

The Buckle BKE Proceeds from maturities of marketable securities

Proceeds from maturities of marketable securities at other companies

EyePoint, Inc. EYPT

$80.93M+76.9%

AbCellera Biologics Inc.ABCL

$143.8M-24.3%

KEE

Keel Infrastructure Corp. Common StockKEEL

$989K-85.7%

NextNavNN

$84M+143%

ZymeworksZYME

$70.18M+50.7%

Oruka Therapeutics, Inc.ORKA

$76.47M-12.3%

Other financials

Income statement

Revenue$288.7M+6.1%

Gross profit$133.5M+5.1%

Operating income$59.5M+36.5%

Net income$46.9M+33.2%

EPS (diluted)$0.92+31.4%

Balance sheet

Cash & equivalents$266.2M-1.0%

Total debt$410.9M+11.1%

Total equity$458.9M+3.1%

Total assets$1.0B+7.3%

Cash flow

Operating cash flow$49.3M+59.2%

CapEx$14.7M+28.6%

Free cash flow$34.7M+77.1%

Valuation

Market cap$2.3B+59.6%

Profitability

Gross margin48.9%+0.1pp

Operating margin21.1%+1.3pp

Net margin16.8%+0.9pp

FCF margin16.8%+0.5pp

Returns & leverage

Return on equity49%+4.4pp

Debt / equity0.9×+0.1×

Current ratio2×-0.1×

Where this comes from

Reported directly by The Buckle in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities.

The official record: The Buckle’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Buckle's proceeds from maturities of marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is The Buckle's proceeds from maturities of marketable securities?: The Buckle (BKE) reported proceeds from maturities of marketable securities of $11.91M in Q1 2026.
How has The Buckle's proceeds from maturities of marketable securities changed year-over-year?: The Buckle's proceeds from maturities of marketable securities increased by 53.1% year-over-year, from $7.78M to $11.91M.